Kezar Life Sciences, Inc. Financial Ratios — KZR Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-25.95	-27.43	-34.37	-34.59	-29.55	-26.37	-39.12	-45.77	-50.63
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	100	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	-1,488.16	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	-1,503.39	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	-230.03	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	-1,455.29	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	-1,455.29	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	-1,455.29	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	6	5	14	21	19	16	2
ST Debt	- -	- -	- -	1	1	1	3	3	9	2
LT Debt	- -	- -	- -	5	4	13	19	16	7	- -
Total Debt/EBITDA	- -	- -	- -	-0.18	-0.13	-0.26	-0.3	-0.18	-0.18	-0.05
Net Debt/EBITDA	1.1	5.95	1.01	0.41	0.51	1	0.44	0.24	0.36	1.4
Total Debt/EBIT	- -	- -	- -	-0.17	-0.13	-0.26	-0.3	-0.18	-0.18	-0.04
Net Debt/EBIT	1.08	5.83	0.98	0.4	0.49	0.97	0.43	0.24	0.35	1.38
EBITDA to Interest Expense	- -	- -	- -	- -	- -	-334.27	-59.19	-67.21	-55.3	-37.5
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	-336.26	-60.52	-68.37	-55.32	-37.5
EBIT to Interest Expense	- -	- -	- -	- -	- -	-343.77	-60.05	-67.89	-55.95	-38.15
Interest Expense	- -	- -	- -	- -	- -	- -	1	2	2	1
Common Equity/Total Assets	-153.27	-48	-42.88	-94.13	-82.97	-82.87	-83.06	-158.54	-300.31	-639.98
Long-Term Debt/Equity (%)	- -	- -	- -	7	3.14	6.52	6.93	8.49	6.36	- -
Long-Term Debt/Capital (%)	- -	- -	- -	-7.01	-3.67	-7.71	-8.22	-4.8	-1.78	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	6.1	2.91	5.89	6.24	7.2	5.14	- -
Total Debt/Equity (%)	- -	- -	- -	8.15	3.88	7.13	7.88	10.09	13.84	3.32
Total Debt/Capital (%)	- -	- -	- -	-8.17	-4.53	-8.43	-9.34	-5.71	-3.87	-0.48
Total Debt/Total Assets (%)	- -	- -	- -	7.11	3.6	6.44	7.1	8.56	11.18	3.03
Net Debt to Equity	55.93	198.67	-22.23	-19.16	-15.06	-27.05	-11.35	-13.55	-26.87	-102.58
Net Debt/Capital (%)	35.76	66.23	32.96	16.1	14.98	23.21	11.43	6.92	6.83	12.83
EBITDA	-9	-9	-24	-36	-41	-53	-70	-104	-88	-51
EBITDA-CapEx	-9	-9	-25	-37	-42	-53	-72	-106	-88	-51
Operating Income (Loss)	-9	-9	-25	-37	-43	-55	-71	-105	-89	-52

Liquidity (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	14.97	34.39	32.19	13.03	21.8	25.37	25.15	11.35	6.51	10.93
Current Ratio	16.11	35.26	32.91	13.52	22.48	25.77	25.98	11.66	6.76	11.52
Quick Ratio	14.97	34.39	32.19	13.03	21.8	25.37	25.15	11.51	6.55	11.24
CFO/Avg Current Liab	- -	-7.6	-8.63	-6.4	-5.94	-5.79	-6.13	-5.68	-3.9	-3.85
Common Equity/Total Assets	-153.27	-48	-42.88	-94.13	-82.97	-82.87	-83.06	-158.54	-300.31	-639.98
Long-Term Debt/Equity (%)	- -	- -	- -	7	3.14	6.52	6.93	8.49	6.36	- -
Long-Term Debt/Capital (%)	- -	- -	- -	-7.01	-3.67	-7.71	-8.22	-4.8	-1.78	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	6.1	2.91	5.89	6.24	7.2	5.14	- -
Total Debt/Equity (%)	- -	- -	- -	8.15	3.88	7.13	7.88	10.09	13.84	3.32
Total Debt/Capital (%)	- -	- -	- -	-8.17	-4.53	-8.43	-9.34	-5.71	-3.87	-0.48
Total Debt/Total Assets (%)	- -	- -	- -	7.11	3.6	6.44	7.1	8.56	11.18	3.03
CFO/Total Liabilities	-33.83	-10.15	-353.31	-260.55	-340.1	-201.53	-198.16	-242.52	-267.28	-787.6
CFO/CapEx	-73.94	-20.85	-18.56	-49.22	-190.46	-134.29	-37.29	-45.11	-2,559.03	-6,472.12
Altman's Z-Score	-3.71	-0.08	246.78	38.35	125.86	250.49	94.98	9.51	-4.21	-5.93

Working Capital (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	2,422	765	2,297	8,821	4,743	687	49	46
- Cash & Cash Equivalents	10	51	24	15	21	63	40	35	42	72
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	6	5	14	21	19	16	2
Enterprise Value	-10	-51	2,315	693	2,162	8,627	4,487	505	-67	-24
Total Capital	-18	-26	-49	-78	-121	-167	-228	-332	-418	-488
Total Debt/Capital (%)	- -	- -	- -	-8.17	-4.53	-8.43	-9.34	-5.71	-3.87	-0.48
Total Debt / EV	- -	- -	- -	0.01	- -	- -	- -	0.04	-0.24	-0.1
EV/Sales	- -	- -	- -	- -	- -	- -	- -	72.09	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	2,422	765	2,297	8,821	4,743	687	49	46
Diluted Enterprise Value	-10	-51	2,398	757	2,281	8,773	4,724	671	23	-24
EV per Share	- -	- -	2,255.34	363.35	491.32	1,635.17	666.1	69.55	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	7	- -	- -
TTM EBITDA	-9	-9	-24	-36	-41	-53	-70	-104	-88	-51
TTM Operating Income	-9	-9	-25	-37	-43	-55	-71	-105	-89	-52
TTM Cash Flow to Firm	-10	-8	-21	-30	-37	-42	-58	-80	-73	-50
TTM Free Cash Flow to Firm	-10	-8	-20	-29	-37	-42	-56	-78	-73	-50

Multiples (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-123.14	-26.14	-62.5	-209.43	-82.82	-8.61	-0.66	-0.89
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-10	-51	2,315	693	2,162	8,627	4,487	505	-67	-24
Low Price	- -	- -	1,477	236	218	461	431	67.5	6.16	3.53
EV/Sales	- -	- -	- -	- -	- -	- -	- -	72.09	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-91.99	-58.01	-51.34	-71.3	-99.34	-19.58	-5.07	-0.66
Price/Earnings High	- -	- -	-160.97	-133.8	-103.21	-166.88	-183.13	-52.99	-9.93	-0.9
Price/Earnings Low	- -	- -	-65.44	-12.84	-22.98	-44.52	-42.55	-4.81	-0.54	-0.46
Price/Book Value	- -	- -	-49.26	-9.08	-18.23	-48.85	-19.06	-1.96	-0.11	-0.09
Price/Book Value Average	- -	- -	-43.34	-24.16	-17.01	-21.57	-27.24	-5.69	-0.98	-0.08
Price/Book Value High	- -	- -	-75.83	-55.71	-34.2	-50.48	-50.22	-15.39	-1.91	-0.1
Price/Book Value Low	- -	- -	-30.83	-5.34	-7.61	-13.47	-11.67	-1.4	-0.1	-0.05
Price/Tangible Book Value	- -	- -	22.27	9.81	16.29	44.81	17.57	3.66	0.42	0.66
Price/Tangible Book Value Average	- -	- -	19.59	26.08	15.2	19.78	25.12	10.63	3.63	0.53
Price/Tangible Book Value High	- -	- -	34.28	60.15	30.56	46.31	46.31	28.78	7.11	0.72
Price/Tangible Book Value Low	- -	- -	13.93	5.77	6.8	12.35	10.76	2.61	0.38	0.37
Price/Sales	- -	- -	- -	- -	- -	- -	- -	98.15	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	284.9	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	771.14	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	69.96	- -	- -
Price/Cash Flow	- -	- -	-116.51	-25.61	-62.17	-207.87	-80.6	-8.42	-0.66	-0.89
Price/Cash Flow Average	- -	- -	-102.5	-68.13	-58	-91.78	-115.2	-24.43	-5.72	-0.72
Price/Cash Flow High	- -	- -	-179.35	-157.13	-116.59	-214.83	-212.37	-66.12	-11.2	-0.98
Price/Cash Flow Low	- -	- -	-72.92	-15.07	-25.96	-57.31	-49.34	-6	-0.61	-0.5
Price/Free Cash Flow Average	- -	- -	-108.34	-69.54	-58.31	-92.47	-118.38	-24.98	-5.73	-0.72
Price/Free Cash Flow High	- -	- -	-189.56	-160.39	-117.21	-216.44	-218.22	-67.61	-11.2	-0.98
Price/Free Cash Flow Low	- -	- -	-77.07	-15.39	-26.1	-57.74	-50.7	-6.13	-0.61	-0.5
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	282.53	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	768.78	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	67.6	- -	- -
EV/EBITDA Average	1.1	5.95	-87.66	-56.24	-51.38	-72.36	-96.38	-18.99	-4.53	0.63
EV/EBITDA High	1.1	5.95	-154.14	-130.02	-103.66	-170.61	-177.9	-51.66	-9.14	0.37
EV/EBITDA Low	1.1	5.95	-62.07	-12.26	-22.79	-44.84	-41.12	-4.54	-0.22	0.85
EV/EBIT Average	1.08	5.83	-85.21	-54.28	-49.53	-70.36	-94.99	-18.79	-4.48	0.62
EV/EBIT High	1.08	5.83	-149.84	-125.49	-99.94	-165.9	-175.34	-51.14	-9.04	0.36
EV/EBIT Low	1.08	5.83	-60.34	-11.83	-21.97	-43.6	-40.53	-4.5	-0.22	0.84
Last Price	- -	- -	2,360	401	522	1,672	704	94.7	6.72	6.29
High Price	- -	- -	3,633	2,460	979	1,728	1,855	744	114	6.93
Enterprise Value Average	-10	-51	2,107	2,027	2,127	3,846	6,760	1,978	399	-33
Enterprise Value High	-10	-51	3,705	4,686	4,292	9,068	12,478	5,381	806	-19
Enterprise Value Low	-10	-51	1,492	442	944	2,383	2,884	473	19	-44

Shares Outstanding	2	2	2	2	5	6	7	7	7	7
Diluted Weighted Avg Shares	1	1	1	2	4	5	7	7	7	7
Basic Weighted Avg Shares	1	1	1	2	4	5	7	7	7	7
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	0.96	- -	- -
EBITDA per Share	-6.79	-6.58	-23.42	-18.89	-9.41	-10.07	-10.41	-14.36	-12.08	-7.02
Operating Income per Share	-6.9	-6.72	-24.09	-19.57	-9.76	-10.36	-10.56	-14.5	-12.23	-7.14
Basic EPS, GAAP	-6.9	-6.54	-22.57	-18.39	-9.49	-10.35	-10.13	-14.04	-11.49	-7.66
Basic EPS from Cont Ops	-6.9	-6.54	-22.57	-18.39	-9.49	-10.35	-10.13	-14.04	-11.49	-7.66
Diluted EPS, GAAP	-6.9	-6.54	-22.57	-18.39	-9.49	-10.35	-10.13	-14.04	-11.49	-7.66
Diluted EPS from Cont Ops	-6.9	-6.54	-22.57	-18.39	-9.49	-10.35	-10.13	-14.04	-11.49	-7.66
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-7.5	-6.23	-20.26	-15.66	-8.4	-8.04	-8.73	-11.25	-10.18	-7.08
Free Cash Flow per Basic Share	-7.6	-6.53	-21.35	-15.97	-8.44	-8.1	-8.97	-11.5	-10.18	-7.08
Cash & Equivalents per Share	7.49	39.19	104.66	40.98	31.92	39.49	41.05	27.75	18.14	9.82
Book Value per Share	-13.45	-19.99	-47.91	-44.15	-28.63	-34.23	-36.93	-48.34	-59.6	-67.04
Tangible Book Value per Share	-13.39	-19.73	105.99	40.9	32.04	37.32	40.06	25.85	16.04	9.58

Kezar Life Sciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)